Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions.
Röhrich M, Daum J, Gutjahr E, Spektor AM, Glatting FM, Sahin YA, Buchholz HG, Hoppner J, Schroeter C, Mavriopoulou E, Schlamp K, Grott M, Eichhorn F, Heußel CP, Kauczor HU, Kreuter M, Giesel F, Schreckenberger M, Winter H, Haberkorn U. Röhrich M, et al. Among authors: eichhorn f. J Nucl Med. 2024 Apr 11:jnumed.123.267103. doi: 10.2967/jnumed.123.267103. Online ahead of print. J Nucl Med. 2024. PMID: 38604763
[Tracheal Tumours].
Eichhorn F, Hoffmann H, Rieken S, Herth FJF, Winter H. Eichhorn F, et al. Zentralbl Chir. 2024 Feb 21. doi: 10.1055/a-2223-1175. Online ahead of print. Zentralbl Chir. 2024. PMID: 38382560 German.
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach.
Klotz LV, Hoffmann H, Shah R, Eichhorn F, Gruenewald C, Bulut EL, Griffo R, Muley T, Christopoulos P, Baum P, Huber P, Safi S, Kriegsmann M, Thomas M, Bischoff H, Winter H, Eichhorn ME. Klotz LV, et al. Among authors: eichhorn f. Transl Lung Cancer Res. 2022 Nov;11(11):2230-2242. doi: 10.21037/tlcr-22-199. Transl Lung Cancer Res. 2022. PMID: 36519024 Free PMC article.
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.
Schindler H, Lusky F, Daniello L, Elshiaty M, Gaissmaier L, Benesova K, Souto-Carneiro M, Angeles AK, Janke F, Eichhorn F, Kazdal D, Schneider M, Liersch S, Klemm S, Schnitzler P, Stenzinger A, Sültmann H, Thomas M, Christopoulos P. Schindler H, et al. Among authors: eichhorn f. Front Oncol. 2022 Oct 31;12:1010660. doi: 10.3389/fonc.2022.1010660. eCollection 2022. Front Oncol. 2022. PMID: 36387148 Free PMC article.
87 results